Stefan Lethagen

发表

Indirect comparisons of efficacy and weekly factor consumption during continuous prophylaxis with recombinant factor VIII Fc fusion protein and conventional recombinant factor VIII products

S. Lethagen, S. Krishnan, P. Karner, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Intranasal and Intravenous Administration of Desmopressin: Effect on F VIII/vWF, Pharmacokinetics and Reproducibility

S. Lethagen, A. Harris, I. Nilsson, 1987, Thrombosis and Haemostasis.

Ins405AsnPro Mutation in the von Willebrand Factor Propeptide in Recessive Type 2A (IIC) von Willebrand’s Disease

S. Lethagen, R. Schneppenheim, L. Holmberg, 1998, Thrombosis and Haemostasis.

Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD)

J. Goudemand, S. Lethagen, J. Eikenboom, 2008, Journal of thrombosis and haemostasis : JTH.

Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study

A. Tosetto, S. Lethagen, J. Eikenboom, 2006, Journal of thrombosis and haemostasis : JTH.

Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.

A. Tosetto, J. Batlle, F. Rodeghiero, 2010, Thrombosis research.

Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM‐1VWD study

J. Goudemand, S. Lethagen, J. Eikenboom, 2009, Journal of Thrombosis and Haemostasis.

von Willebrand factor/factor VIII concentrate (Haemate® P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery

P. Mannucci, P. Kyrle, S. Lethagen, 2007, Journal of thrombosis and haemostasis : JTH.

Classification of von Willebrand disease: emerging issues

S. Lethagen, L. Holmberg, Lars Holmberg, 1999, Haemophilia : the official journal of the World Federation of Hemophilia.

Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype

A. Johansson, C. Halldén, S. Lethagen, 2005, Journal of thrombosis and haemostasis : JTH.

Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1VWD)

A. Tosetto, J. Goudemand, S. Lethagen, 2007, Journal of thrombosis and haemostasis : JTH.

Effects of desmopressin acetate (DDAVP) and dextran on hemostatic and thromboprophylactic mechanisms.

S. Lethagen, M. Åberg, I. Nilsson, 1990, Acta chirurgica Scandinavica.

Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand’s disease (VWD) has limited value in dosing for surgery

P. Mannucci, S. Lethagen, J. Gill, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin.

S. Lethagen, A. Harris, I. Nilsson, 1988, Journal of pharmaceutical sciences.